Effect of prostaglandin analogues on anterior scleral thickness and corneal thickness in patients with primary open-angle glaucoma
Abstract Prostaglandin (PG) analogues are usually prescribed as a first-line therapy in patients with glaucoma because of its once-daily dosing benefit and effective intraocular pressure (IOP) reduction. However, the mechanism of PG analogues is not completely understood. In this study, we investiga...
Guardado en:
Autores principales: | Ji-Hye Park, Chungkwon Yoo, Hyun Woo Chung, Yong Yeon Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6a3d5f284a7a4d8ca7d71bae717c817a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
No differences in central corneal thickness between open-angle and pseudoexfoliation glaucoma patients
por: Ayala M, et al.
Publicado: (2017) -
Clinical Analysis of Macular Choroidal Thickness in Pseudoexfoliative Glaucoma and Primary Open-Angle Glaucoma
por: Fan Li, et al.
Publicado: (2021) -
Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis
por: Oghenowede Eyawo, et al.
Publicado: (2009) -
A pilot study of scleral thickness in central serous chorioretinopathy using anterior segment optical coherence tomography
por: Yun Ji Lee, et al.
Publicado: (2021) -
Comparative Study of Lamina Cribrosa Thickness Between Primary Angle-Closure and Primary Open-Angle Glaucoma
por: Wanichwecharungruang B, et al.
Publicado: (2021)